Yin Yeshi, Chen Huahai, Cao Linyan, Tang Lin, He Fulin
Key Laboratory of Comprehensive Utilization of Advantage Plants Resources in Hunan South, College of Chemistry and Bioengineering, Hunan University of Science and Engineering, Yongzhou 425199, Hunan, China.
Sheng Wu Gong Cheng Xue Bao. 2018 Aug 25;34(8):1346-1360. doi: 10.13345/j.cjb.180223.
Antimicrobial resistance is on the rise while the number of antibiotics being brought to market continues to drop. Drug-resistant genes and drug-resistant bacteria infection have seriously threatened human health. Therefore, antimicrobial resistance presents an ongoing challenge that requires multifaceted approaches including: biomedical innovation; improved surveillance of antibiotic consumption and antimicrobial resistance generated rates; prevention of health-care-associated infections and transmission of multidrug-resistant bacteria and environmental dissemination; rapid microbiological diagnosis; and curtailed clinical and veterinary misuse. Fortunately, combating antimicrobial resistance has been highly valued and supported by the government, scientists and entrepreneurs of various countries. With the continuous introduction of new technologies, new products, and new management measures, the problem of antimicrobial resistance must be controlled and alleviated.
抗生素耐药性正在上升,而进入市场的抗生素数量却持续下降。耐药基因和耐药菌感染已严重威胁人类健康。因此,抗生素耐药性构成了一项持续的挑战,需要多方面的应对措施,包括:生物医学创新;加强对抗生素消费和产生耐药性比率的监测;预防医疗保健相关感染以及多重耐药菌的传播和环境扩散;快速微生物诊断;以及减少临床和兽医领域的滥用。幸运的是,对抗生素耐药性的斗争已得到各国政府、科学家和企业家的高度重视与支持。随着新技术、新产品和新管理措施的不断推出,抗生素耐药性问题必将得到控制和缓解。